Pharmaceuticals

Global Epilepsy Drugs Market 2016-2020

  • TEC620391
  • 87 Pages
  • July 2016
  • Pharmaceuticals
About the Epilepsy Drugs Market

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
Etiology
Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.

Technavios analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Eisai
GSK
Pfizer
UCB

Other prominent vendors
AbbVie
Acorda Therapeutics
Alexza Pharmaceuticals
Aprecia Pharmaceuticals
Aurobindo Pharma
Biscayne Pharmaceuticals
CURx Pharmaceuticals
Dainippon Sumitomo Pharma
D-Pharm
F. Hoffmann-La Roche
Grupo Ferrer Internacional
GW Pharmaceuticals
Insero Health
INSYS Therapeutics
Janssen Pharmaceuticals
Ligand Pharmaceuticals
H. Lundbeck
MarcoPolo Pharmaceuticals
Marinus Pharmaceuticals
Meda
Neurelis
Nobelpharma
Novartis
Orphelia Pharma
SAGE Therapeutics
SciFlour
Sedor Pharmaceuticals
Shire
SK Biopharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals (US)
Supernus Pharmaceuticals
Takeda
Turing Pharmaceuticals
Upsher-Smith
Valeant Pharmaceutical
Zogenix

Market driver
Tentative approval of late-stage pipeline molecules
For a full, detailed list, view our report

Market challenge
Social stigma associated with epilepsy
For a full, detailed list, view our report

Market trend
Reformulation of marketed drugs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Large Volume Parenteral (LPV) Market (Treatment Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Weight Loss and Obesity Market (Dietary supplements, equipments, services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Obesity is a medical term used when excessive accumulation of fat occurs in the body. It may have numerous adverse effects on health, which increases the chances of occurrence of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Dilated Cardiomyopathy Asia-Pacific Market Research Report, 2014 - 2020

Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently. It could have negative impact ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Antiemetics Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics,

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Global Lung Cancer Therapeutics Market (Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Lung cancer is a malignant lung carcinoma that is characterized by abnormal cell growth in lung tissue. As the tumor grows in size, it decreases the lungs ability to provide ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>